These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29416936)

  • 21. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More than hemifacial spasm? A case of unilateral facial spasms with systematic review of red flags.
    Sringean J; Dressler D; Bhidayasiri R
    J Neurol Sci; 2019 Dec; 407():116532. PubMed ID: 31683060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemimasticatory spasm treated with microvascular decompression of the trigeminal nerve.
    Chon KH; Lee JM; Koh EJ; Choi HY
    Acta Neurochir (Wien); 2012 Sep; 154(9):1635-9. PubMed ID: 22576267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chewing-induced facial dystonia.
    Yang SS; Seet RC; Lim EC
    Ann Acad Med Singap; 2010 Sep; 39(9):740-2. PubMed ID: 20957311
    [No Abstract]   [Full Text] [Related]  

  • 25. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
    Schellini SA; Matai O; Igami TZ; Padovani CR; Padovani CP
    Arq Bras Oftalmol; 2006; 69(1):23-6. PubMed ID: 16491229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of painful hemimasticatory spasm with masseter muscle hypertrophy responsive to botulinum toxin.
    Kim JH; Han SW; Kim YJ; Kim J; Oh MS; Ma HI; Lee BC
    J Mov Disord; 2009 Oct; 2(2):95-7. PubMed ID: 24868368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of botulinum toxin type a for patients with painful tic convulsif.
    Micheli F; Scorticati MC; Raina G
    Clin Neuropharmacol; 2002; 25(5):260-2. PubMed ID: 12410057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Headache in hemifacial spasm patients.
    Peeraully T; Tan SF; Fook-Chong SM; Prakash KM; Tan EK
    Acta Neurol Scand; 2013 May; 127(5):e24-7. PubMed ID: 23311349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local injection of botulinum toxin type A for hemifacial spasm.
    Oyama H; Ikeda A; Inoue S; Nakashima Y; Shibuya M
    Neurol Med Chir (Tokyo); 2002 Jun; 42(6):245-8; discussion 248-9. PubMed ID: 12116529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases.
    Grosset DG; Tyrrell EG; Grosset KA
    J Rehabil Med; 2015 Feb; 47(2):183-6. PubMed ID: 25325305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral glaucomatous damage in a patient with hemifacial spasm.
    Killer HE; Rüst O; Müller O; Flammer J
    Ophthalmologica; 1999; 213(4):273-5. PubMed ID: 10420114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of fillers as adjunct therapy for the treatment of lower face hemifacial spasm.
    Borodic GE
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):225-6. PubMed ID: 23559346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and treatment status of hemifacial spasm in China.
    Wang L; Hu X; Dong H; Wang W; Huang Y; Jin L; Luo Y; Zhang W; Lian Y; Liang Z; Shang H; Feng Y; Wu Y; Chen J; Luo W; Wan X
    Chin Med J (Engl); 2014; 127(5):845-9. PubMed ID: 24571874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the effects of Botulinum Toxin A on tear metrics in patients with hemifacial spasm.
    Mali YP; Schultze RL; Wladis EJ
    Orbit; 2017 Oct; 36(5):307-310. PubMed ID: 28627956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral hemifacial spasm and trigeminal neuralgia: a unique form of painful tic convulsif.
    Felicio AC; Godeiro Cde O; Borges V; Silva SM; Ferraz HB
    Mov Disord; 2007 Jan; 22(2):285-6. PubMed ID: 17083101
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.
    Jost WH; Kohl A
    J Neurol; 2001 Apr; 248 Suppl 1():21-4. PubMed ID: 11357234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvascular Decompression for Hemimasticatory Spasm: A Case Report and Review of the Literature.
    Sun H; Wei Z; Wang Y; Liu C; Chen M; Diao Y
    World Neurosurg; 2016 Jun; 90():703.e5-703.e10. PubMed ID: 26931542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm.
    Ishikawa M; Takashima K; Kamochi H; Kusaka G; Shinoda S; Watanabe E
    Neurol Res; 2010 Jul; 32(6):656-60. PubMed ID: 19660185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parry-Romberg Syndrome With Hemimasticatory Spasm: A Rare Combination.
    Chen GC; Chen MJ; Wei WB; Hao YB
    J Craniofac Surg; 2020; 31(2):e205-e208. PubMed ID: 31977713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.